モバイルヘルスの世界市場:種類別(サービス、デバイス)、サービス別(監視サービス、診断サービス、ヘルスケアシステム強化サービス、その他)、デバイス別(BPモニター、心臓モニター、脈拍酸素濃度計、血糖計、無呼吸・睡眠モニター、神経モニター、ウェアラブルフィットネスセンサーデバイス・心拍数メーター、その他)、ステークホルダー別(モバイルオペレーター、デバイスベンダー、ヘルスケアプロバイダー、コンテンツプレーヤー)、用途別(心臓血管疾患、糖尿病、呼吸器、神経、その他)、地域別

◆英語タイトル:Global mHealth Market By Type (Services and Devices) By Services (Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others) By Devices (BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others) By Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers and Content Players) By Application (Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications) By Region, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20JN130
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年4月
◆ページ数:377
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様利用)USD3,600 ⇒換算¥374,400見積依頼/購入/質問フォーム
Global License(法人利用)USD6,048 ⇒換算¥628,992見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートは、モバイルヘルスの世界市場の現状と展望が網羅的に把握できるレポートです。モバイルヘルスの世界市場について、市場範囲・調査手法、市場動向、競争分析、種類別(サービス、デバイス)分析、サービス種類別(監視サービス、診断サービス、医療システム強化サービス、その他)分析、デバイス種類別(BPモニター、心臓モニター、パルスオキシメーター、血糖値計、無呼吸・睡眠モニター、神経モニター)分析、ステークホルダー別(携帯電話会社、デバイスベンダー、ヘルスケアプロバイダー、コンテンツプレーヤー)分析、用途別(心血管疾患、糖尿病、呼吸器、神経学、その他)分析、地域別分析、企業概要などを把握し、将来性を考察しております。
・市場範囲・調査手法
・市場動向
・競争分析
・モバイルヘルスの世界市場:種類別(サービス、デバイス)
・モバイルヘルスの世界市場:サービス種類別(監視サービス、診断サービス、医療システム強化サービス、その他)
・モバイルヘルスの世界市場:デバイス種類別(BPモニター、心臓モニター、パルスオキシメーター、血糖値計、無呼吸・睡眠モニター、神経モニター)
・モバイルヘルスの世界市場:ステークホルダー別(携帯電話会社、デバイスベンダー、ヘルスケアプロバイダー、コンテンツプレーヤー)
・モバイルヘルスの世界市場:用途別(心血管疾患、糖尿病、呼吸器、神経学、その他)
・モバイルヘルスの世界市場:地域別
・企業概要
【レポートの概要】

The Global mHealth Market size is expected to reach $206.1 billion by 2026, rising at a market growth of 31.6% CAGR during the forecast period. Mobile health (mHealth) refers to the practice of mobile-supported public health and treatment, such as smartphones, personal digital assistants, tablets, and wireless systems. Under digital health, mHealth covers both multimedia and telecommunications infrastructure technologies for delivering health information.
mHealth applications include; education & awareness, assistance for diagnosis & treatment, management of the health care supply chain, remote monitoring, management of chronic diseases, among others. The mHealth industry is expected to witness substantial growth over the projected period as mHealth facilities are increasing globally. Increasing demand for home-based remote patient monitoring services for the aged population is also a key factor in fueling growth in the mHealth market.
Some of the prominent developments the industry is experiencing include growing application of cloud-based mhealth applications through healthcare, growing use of mhealth applications for customized patient experience, as well as remote tracking and increasing emphasis on consumer-centered connectivity solutions.
Growing innovations in preventive healthcare and increased funding for mHealth start-ups are also driving the market growth. Mobile healthcare applications are gaining momentum in the healthcare sector with the advent of numerous digital start-ups. In addition, the rise in adoption of mHealth is due to factors such as increased penetration of smartphones, high internet use, and the easy availability of mHealth apps.
In addition, recent developments in wearable technology and a growing prevalence of chronic diseases, particularly cardiovascular disorders and diabetes, have contributed significantly to the growth of the segment. Aside from technical advances, a viable business model and strategic partnerships are the two most important factors for businesses to create structured revenue channels. Nonetheless, factors such as data protection issues and poor network coverage can hinder the market growth.
mHealth apps are expected to see a lucrative growth rate over the projected period due to strong consumer demand. Increased adoption of wearables by patients and the health-conscious population would also have a positive effect on the market. It has been observed that the majority of digital healthcare start-ups have adopted the B2C business model, which allows faster adoption compared to multi-stakeholder structures in the primary healthcare sector.
Based on Type, the market is segmented into Services and Devices. Based on Services, the market is segmented into Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others. Based on Devices, the market is segmented into BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others. Based on Stakeholders, the market is segmented into Mobile Operators, Device Vendors, Healthcare Providers and Content Players. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix, Johnson and Johnson, Medtronic PLC, Samsung Electronics Co., Ltd., and Bayer AG are the forerunners in the mHealth Market. Companies such as DexCom, Inc., Koninklijke Philips N.V., AllScripts Healthcare Solutions, Inc., Omron Corporation, Cerner Corporation, and Sanofi S.A. are some of the key innovators in mHealth Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Medtronic PLC, Johnson and Johnson, Koninklijke Philips N.V., DexCom, Inc., Samsung Electronics Co., Ltd. (Samsung Group), Omron Corporation, AllScripts Healthcare Solutions, Inc., Sanofi S.A., Cerner Corporation.
Recent strategies deployed in mHealth Market
Partnerships, Collaborations, and Agreements:
Feb-2020: DexCom signed a commercialization agreement with Insulet Corporation, a medical device company. Under this agreement, the companies aimed to combine current and future Dexcom continuous glucose monitoring systems (CGM) with Insulet’s trusted tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery.
Feb-2020: Johnson and Johnson announced it is partnering with Apple for a new mHealth study. The study would determine whether the Apple Watch and an accompanying app can help reduce the risk of stroke in older Americans. The Heartline Study is open to more than 40 million seniors enrolled in Medicare. The aim is to determine whether the ECG sensor and app on the Apple Watch can accurately detect the presence of atrial fibrillation, a key indicator of stroke susceptibility.
Jan-2020: Sanofi signed an agreement with BIOCORP, a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems. The agreement was signed for BIOCORP’s smart sensor Mallya. The smart sensor will record the dosage when a person uses a SoloStar pen to administer insulin. This information would be combined with blood glucose levels recorded by Sanofi’s digital monitoring platform, which currently includes the MyStar DoseCoach blood glucose meter and the My Dose Coach smartphone app.
Jan-2020: DexCom announced partnership with Livongo, a leading Applied Health Signals company. The partnership would offer Livongo Members the ability to synch data from their Dexcom G6 Continuous Glucose Monitoring System with the Livongo platform, providing access to key insights and Health Nudges from Livongo’s Applied Health Signals platform based on their CGM data.
Dec-2019: DexCom signed a global commercialization agreement with Eli Lilly and Company. Under this agreement, the former company products would be integrated into the latter company’s personalized diabetes management system. Lilly would use Dexcom’s continuous glucose monitoring (CGM) devices in both the pen- and pump-based platforms of the system being designed to help improve diabetes management.
Oct-2019: AllScripts collaborated with Northwell Health, New York’s largest health system. Following this partnership, the companies would develop a next-generation EHR. This next-generation EHR would be cloud-based, voice-enabled, and artificially intelligence-based. It would be designed and tested by Northwell’s clinicians, technology experts, and administrators with the aim of it being deployed systemwide. The product would optimize the patients’ experience and enhance healthcare delivery to improve the experience for both clinicians and patients alike.
Oct-2019: Cerner collaborated with ResMed, a digital health company. Following this collaboration, the companies aimed to help providers make more informed treatment decisions, control costs, and deliver seamless care across health systems to the home.
Sep-2019: Sanofi came into partnership with Happify Health, a digital therapeutics company. Under this partnership, the former company was aimed to develop a mHealth platform that would help people living with multiple sclerosis who are also having mental health problems. Both companies would develop a mHealth app that would use digital cognitive behavioral therapy to MS patients who are dealing with depression or anxiety.
Sep-2019: Sanofi partnered with Abbott following which the companies integrated glucose sensing and insulin delivery technologies. This integration would help to further simplify how people with diabetes manage their condition. Both the companies have connected care by developing tools that combine the FreeStyle Libre technology with insulin dosing information for future smartpens, insulin titration apps, and cloud software.
Aug-2019: Bayer announced collaboration with Sensyne Health, a British artificial intelligence technology company. The collaboration was aimed to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health’s proprietary clinical AI technology platform.
Jul-2019: AllScripts signed a collaboration agreement with Microsoft. The collaboration was focused on enabling interoperability between different technology platforms and streamlining EHR data sharing for Microsoft HealthVault users. The current members of Microsoft HealthVault would have the opportunity to transition their EHR data to AllScripts’ FollowMyHealth patient portal to ensure friends, family, and home care teams have access to their health information when needed.
Apr-2019: Medtronic signed an agreement with Blue Cross and Blue Shield of Minnesota. Through this agreement, the Blue Cross members’ can receive the Guardian Connect glucose monitoring system as a pharmacy benefit, which will make it easier for patients to access the technology.
Mar-2019: AllScripts announced that it is partnering with Ephraim McDowell Health. The partnership was aimed at enhancing its patient portal tool, FollowMyHealth. The enhancement efforts were focused on developing a more holistic patient engagement technology experience. While the current patient portal model is useful for creating patient data access and facilitating secure direct messages with patients and providers, Allscripts and Ephraim McDowell Health plan to create an all-encompassing patient experience.
Feb-2019: Omron Healthcare teamed up with physIQ, Inc. for combining Omron’s HeartGuide, the first wearable blood pressure monitor into the pinpointIQ platform. The integration enables the companies to monitor at-risk patients in an outpatient setting. The collaboration was aimed to generate actionable clinical information for at-risk patients in an outpatient environment by using the technologies of each company.
Acquisition and Mergers:
Dec-2019: Medtronic acquired Klue, a software company focused on behavior tracking that can provide real-time insights into when a person is consuming food. The Klue technology can be used to accelerate the company’s market-leading analytics and insights in their smart CGM technology for helping people using multiple daily injections (MDI) stay ahead of high and low glucose events.
Aug-2018: DexCom acquired TypeZero Technologies, a digital health and personalized Medicine Company. The acquisition enabled the company to further strengthen its portfolio.
May-2018: AllScripts signed an agreement to acquire HealthGrid Holding Co., the developer of a mobile patient engagement platform called CareNotify. The acquisition would strengthen the company’s FollowMyHealth platform and advance its EHR-agnostic approach.
May-2018: Royal Philips acquired NightBalance, a digital health scale-up company. The acquisition helped the company in further expanding its leadership position in the growing home care market, and its ability to deliver integrated solutions for efficiencies and improved outcomes.
Product Launches and Product Expansions:
Sep-2019: Royal Philips launched Philips NightBalance, a prescription sleep position therapy device. This device has been designed for patients with positional obstructive sleep apnea (OSA). Philips NightBalance uses gentle vibrations for helping users in altering their sleeping positions to help prevent apneas.
Sep-2018: Phillips Africa unveiled Lumify, its first app-based ultrasound solution. The solution enabled the healthcare professionals, irrespective of location, to easily carry out an ultrasound. The Lumify ultrasound helps healthcare providers guide diagnosis, treatment, and management in ways for which ultrasound isn’t currently used.
Jan-2018: Omron Healthcare launched the two new Blood Pressure Monitors (BPM) HEM-7270 and HEM-7124 with inbuilt unique Intellisence Technology. The technology enables Omron blood pressure monitors to inflate and deflate at the optimum level for each user which offers an accurate reading.
Jan-2018: Omron Healthcare introduced the Omron HeartGuide, the first wearable oscillometric wrist blood pressure monitor; and the Omron Blood Pressure Monitor, EKG, the first single at-home device in the U.S. that measures blood pressure and EKG. The company also previewed its new Omron Connect App, which syncs with Omron connected devices so consumers can store, track, and share heart health data with their doctors for better treatment and better outcomes.
Scope of the Study

Market Segmentation:
By Type
• Services and
• Devices

By Services
• Monitoring services
• Diagnosis services
• Healthcare Systems Strengthening Services and
• Others

By Devices
• BP Monitors
• Cardiac Monitors
• Pulse Oximetry
• Blood Glucose Meters
• Apnea & Sleep Monitors
• Neurological Monitors
• Wearable Fitness Sensor Device & Heart Rate Meters and
• Others

By Stakeholders
• Mobile Operators
• Device Vendors
• Healthcare Providers and

Content Players
• By Application
• Cardiovascular Diseases
• Diabetes
• Respiratory
• Neurology and
• Other Applications

By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA

Companies Profiled
• Bayer AG
• Medtronic PLC
• Johnson and Johnson
• Koninklijke Philips N.V.
• DexCom, Inc.
• Samsung Electronics Co., Ltd. (Samsung Group)
• Omron Corporation
• AllScripts Healthcare Solutions, Inc.
• Sanofi S.A.
• Cerner Corporation

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global mHealth Market, by Type
1.4.2 Global mHealth Market, by Services
1.4.3 Global mHealth Market, by Devices
1.4.4 Global mHealth Market, by Stakeholders
1.4.5 Global mHealth Market, by Application
1.4.6 Global mHealth Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2015, Jun – 2020,Feb) Leading Players
Chapter 4. Global mHealth Market by Type
4.1 Global Services Market by Region
4.2 Global Devices Market by Region
Chapter 5. Global mHealth Services Market by Type
5.1 Global Monitoring services Market by Region
5.2 Global Diagnosis services Market by Region
5.3 Global Healthcare Systems Strengthening Services Market by Region
5.4 Global Other Services Market by Region
Chapter 6. Global mHealth Devices Market by Type
6.1 Global BP Monitors Market by Region
6.2 Global Cardiac Monitors Market by Region
6.3 Global Pulse Oximetry Market by Region
6.4 Global Blood Glucose Meters Market by Region
6.5 Global Apnea & Sleep Monitors Market by Region
6.6 Global Neurological Monitors Market by Region
6.7 Global Wearable Fitness Sensor Device & Heart Rate Meters Market by Region
6.8 Global Others Market by Region
Chapter 7. Global mHealth Market by Stakeholders
7.1 Global Mobile Operators Market by Region
7.2 Global Device Vendors Market by Region
7.3 Global Healthcare Providers Market by Region
7.4 Global Content Players Market by Region
Chapter 8. Global mHealth Market by Applications
8.1 Global Cardiovascular Diseases Market by Region
8.2 Global Diabetes Market by Region
8.3 Global Respiratory Market by Region
8.4 Global Neurology Market by Region
8.5 Global Other Applications Market by Region
Chapter 9. Global mHealth Market by Region
9.1 North America mHealth Market
9.1.1 North America mHealth Market by Type
9.1.1.1 North America Services Market by Country
9.1.1.2 North America mHealth Services Market by Type
9.1.1.2.1 North America Monitoring services Market by Country
9.1.1.2.2 North America Diagnosis services Market by Country
9.1.1.2.3 North America Healthcare Systems Strengthening Services Market by Country
9.1.1.2.4 North America Other Services Market by Country
9.1.1.3 North America Devices Market by Country
9.1.1.4 North America mHealth Devices Market by Type
9.1.1.4.1 North America BP Monitors Market by Country
9.1.1.4.2 North America Cardiac Monitors Market by Country
9.1.1.4.3 North America Pulse Oximetry Market by Country
9.1.1.4.4 North America Blood Glucose Meters Market by Country
9.1.1.4.5 North America Apnea & Sleep Monitors Market by Country
9.1.1.4.6 North America Neurological Monitors Market by Country
9.1.1.4.7 North America Wearable Fitness Sensor Device & Heart Rate Meters Market by Country
9.1.1.4.8 North America Others Market by Country
9.1.2 North America mHealth Market by Stakeholders
9.1.2.1 North America Mobile Operators Market by Country
9.1.2.2 North America Device Vendors Market by Country
9.1.2.3 North America Healthcare Providers Market by Country
9.1.2.4 North America Content Players Market by Country
9.1.3 North America mHealth Market by Applications
9.1.3.1 North America Cardiovascular Diseases Market by Country
9.1.3.2 North America Diabetes Market by Country
9.1.3.3 North America Respiratory Market by Country
9.1.3.4 North America Neurology Market by Country
9.1.3.5 North America Other Applications Market by Country
9.1.4 North America mHealth Market by Country
9.1.4.1 US mHealth Market
9.1.4.1.1 US mHealth Market by Type
9.1.4.1.2 US mHealth Market by Stakeholders
9.1.4.1.3 US mHealth Market by Applications
9.1.4.2 Canada mHealth Market
9.1.4.2.1 Canada mHealth Market by Type
9.1.4.2.2 Canada mHealth Market by Stakeholders
9.1.4.2.3 Canada mHealth Market by Applications
9.1.4.3 Mexico mHealth Market
9.1.4.3.1 Mexico mHealth Market by Type
9.1.4.3.2 Mexico mHealth Market by Stakeholders
9.1.4.3.3 Mexico mHealth Market by Applications
9.1.4.4 Rest of North America mHealth Market
9.1.4.4.1 Rest of North America mHealth Market by Type
9.1.4.4.2 Rest of North America mHealth Market by Stakeholders
9.1.4.4.3 Rest of North America mHealth Market by Applications
9.2 Europe mHealth Market
9.2.1 Europe mHealth Market by Type
9.2.1.1 Europe Services Market by Country
9.2.1.2 Europe mHealth Services Market by Type
9.2.1.2.1 Europe Monitoring services Market by Country
9.2.1.2.2 Europe Diagnosis services Market by Country
9.2.1.2.3 Europe Healthcare Systems Strengthening Services Market by Country
9.2.1.2.4 Europe Other Services Market by Country
9.2.1.3 Europe Devices Market by Country
9.2.1.4 Europe mHealth Devices Market by Type
9.2.1.4.1 Europe BP Monitors Market by Country
9.2.1.4.2 Europe Cardiac Monitors Market by Country
9.2.1.4.3 Europe Pulse Oximetry Market by Country
9.2.1.4.4 Europe Blood Glucose Meters Market by Country
9.2.1.4.5 Europe Apnea & Sleep Monitors Market by Country
9.2.1.4.6 Europe Neurological Monitors Market by Country
9.2.1.4.7 Europe Wearable Fitness Sensor Device & Heart Rate Meters Market by Country
9.2.1.4.8 Europe Others Market by Country
9.2.2 Europe mHealth Market by Stakeholders
9.2.2.1 Europe Mobile Operators Market by Country
9.2.2.2 Europe Device Vendors Market by Country
9.2.2.3 Europe Healthcare Providers Market by Country
9.2.2.4 Europe Content Players Market by Country
9.2.3 Europe mHealth Market by Applications
9.2.3.1 Europe Cardiovascular Diseases Market by Country
9.2.3.2 Europe Diabetes Market by Country
9.2.3.3 Europe Respiratory Market by Country
9.2.3.4 Europe Neurology Market by Country
9.2.3.5 Europe Other Applications Market by Country
9.2.4 Europe mHealth Market by Country
9.2.4.1 Germany mHealth Market
9.2.4.1.1 Germany mHealth Market by Type
9.2.4.1.2 Germany mHealth Market by Stakeholders
9.2.4.1.3 Germany mHealth Market by Applications
9.2.4.2 UK mHealth Market
9.2.4.2.1 UK mHealth Market by Type
9.2.4.2.2 UK mHealth Market by Stakeholders
9.2.4.2.3 UK mHealth Market by Applications
9.2.4.3 France mHealth Market
9.2.4.3.1 France mHealth Market by Type
9.2.4.3.2 France mHealth Market by Stakeholders
9.2.4.3.3 France mHealth Market by Applications
9.2.4.4 Russia mHealth Market
9.2.4.4.1 Russia mHealth Market by Type
9.2.4.4.2 Russia mHealth Market by Stakeholders
9.2.4.4.3 Russia mHealth Market by Applications
9.2.4.5 Spain mHealth Market
9.2.4.5.1 Spain mHealth Market by Type
9.2.4.5.2 Spain mHealth Market by Stakeholders
9.2.4.5.3 Spain mHealth Market by Applications
9.2.4.6 Italy mHealth Market
9.2.4.6.1 Italy mHealth Market by Type
9.2.4.6.2 Italy mHealth Market by Stakeholders
9.2.4.6.3 Italy mHealth Market by Applications
9.2.4.7 Rest of Europe mHealth Market
9.2.4.7.1 Rest of Europe mHealth Market by Type
9.2.4.7.2 Rest of Europe mHealth Market by Stakeholders
9.2.4.7.3 Rest of Europe mHealth Market by Applications
9.3 Asia Pacific mHealth Market
9.3.1 Asia Pacific mHealth Market by Type
9.3.1.1 Asia Pacific Services Market by Country
9.3.1.2 Asia Pacific mHealth Services Market by Type
9.3.1.2.1 Asia Pacific Monitoring services Market by Country
9.3.1.2.2 Asia Pacific Diagnosis services Market by Country
9.3.1.2.3 Asia Pacific Healthcare Systems Strengthening Services Market by Country
9.3.1.2.4 Asia Pacific Other Services Market by Country
9.3.1.3 Asia Pacific Devices Market by Country
9.3.1.4 Asia Pacific mHealth Devices Market by Type
9.3.1.4.1 Asia Pacific BP Monitors Market by Country
9.3.1.4.2 Asia Pacific Cardiac Monitors Market by Country
9.3.1.4.3 Asia Pacific Pulse Oximetry Market by Country
9.3.1.4.4 Asia Pacific Blood Glucose Meters Market by Country
9.3.1.4.5 Asia Pacific Apnea & Sleep Monitors Market by Country
9.3.1.4.6 Asia Pacific Neurological Monitors Market by Country
9.3.1.4.7 Asia Pacific Wearable Fitness Sensor Device & Heart Rate Meters Market by Country
9.3.1.4.8 Asia Pacific Others Market by Country
9.3.2 Asia Pacific mHealth Market by Stakeholders
9.3.2.1 Asia Pacific Mobile Operators Market by Country
9.3.2.2 Asia Pacific Device Vendors Market by Country
9.3.2.3 Asia Pacific Healthcare Providers Market by Country
9.3.2.4 Asia Pacific Content Players Market by Country
9.3.3 Asia Pacific mHealth Market by Applications
9.3.3.1 Asia Pacific Cardiovascular Diseases Market by Country
9.3.3.2 Asia Pacific Diabetes Market by Country
9.3.3.3 Asia Pacific Respiratory Market by Country
9.3.3.4 Asia Pacific Neurology Market by Country
9.3.3.5 Asia Pacific Other Applications Market by Country
9.3.4 Asia Pacific mHealth Market by Country
9.3.4.1 China mHealth Market
9.3.4.1.1 China mHealth Market by Type
9.3.4.1.2 China mHealth Market by Stakeholders
9.3.4.1.3 China mHealth Market by Applications
9.3.4.2 Japan mHealth Market
9.3.4.2.1 Japan mHealth Market by Type
9.3.4.2.2 Japan mHealth Market by Stakeholders
9.3.4.2.3 Japan mHealth Market by Applications
9.3.4.3 India mHealth Market
9.3.4.3.1 India mHealth Market by Type
9.3.4.3.2 India mHealth Market by Stakeholders
9.3.4.3.3 India mHealth Market by Applications
9.3.4.4 South Korea mHealth Market
9.3.4.4.1 South Korea mHealth Market by Type
9.3.4.4.2 South Korea mHealth Market by Stakeholders
9.3.4.4.3 South Korea mHealth Market by Applications
9.3.4.5 Singapore mHealth Market
9.3.4.5.1 Singapore mHealth Market by Type
9.3.4.5.2 Singapore mHealth Market by Stakeholders
9.3.4.5.3 Singapore mHealth Market by Applications
9.3.4.6 Malaysia mHealth Market
9.3.4.6.1 Malaysia mHealth Market by Type
9.3.4.6.2 Malaysia mHealth Market by Stakeholders
9.3.4.6.3 Malaysia mHealth Market by Applications
9.3.4.7 Rest of Asia Pacific mHealth Market
9.3.4.7.1 Rest of Asia Pacific mHealth Market by Type
9.3.4.7.2 Rest of Asia Pacific mHealth Market by Stakeholders
9.3.4.7.3 Rest of Asia Pacific mHealth Market by Applications
9.4 LAMEA mHealth Market
9.4.1 LAMEA mHealth Market by Type
9.4.1.1 LAMEA Services Market by Country
9.4.1.2 LAMEA mHealth Services Market by Type
9.4.1.2.1 LAMEA Monitoring services Market by Country
9.4.1.2.2 LAMEA Diagnosis services Market by Country
9.4.1.2.3 LAMEA Healthcare Systems Strengthening Services Market by Country
9.4.1.2.4 LAMEA Other Services Market by Country
9.4.1.3 LAMEA Devices Market by Country
9.4.1.4 LAMEA mHealth Devices Market by Type
9.4.1.4.1 LAMEA BP Monitors Market by Country
9.4.1.4.2 LAMEA Cardiac Monitors Market by Country
9.4.1.4.3 LAMEA Pulse Oximetry Market by Country
9.4.1.4.4 LAMEA Blood Glucose Meters Market by Country
9.4.1.4.5 LAMEA Apnea & Sleep Monitors Market by Country
9.4.1.4.6 LAMEA Neurological Monitors Market by Country
9.4.1.4.7 LAMEA Wearable Fitness Sensor Device & Heart Rate Meter Market by Country
9.4.1.4.8 LAMEA Others Market by Country
9.4.2 LAMEA mHealth Market by Stakeholders
9.4.2.1 LAMEA Mobile Operators Market by Country
9.4.2.2 LAMEA Device Vendors Market by Country
9.4.2.3 LAMEA Healthcare Providers Market by Country
9.4.2.4 LAMEA Content Players Market by Country
9.4.3 LAMEA mHealth Market by Applications
9.4.3.1 LAMEA Cardiovascular Diseases Market by Country
9.4.3.2 LAMEA Diabetes Market by Country
9.4.3.3 LAMEA Respiratory Market by Country
9.4.3.4 LAMEA Neurology Market by Country
9.4.3.5 LAMEA Other Applications Market by Country
9.4.4 LAMEA mHealth Market by Country
9.4.4.1 Brazil mHealth Market
9.4.4.1.1 Brazil mHealth Market by Type
9.4.4.1.2 Brazil mHealth Market by Stakeholders
9.4.4.1.3 Brazil mHealth Market by Applications
9.4.4.2 Argentina mHealth Market
9.4.4.2.1 Argentina mHealth Market by Type
9.4.4.2.2 Argentina mHealth Market by Stakeholders
9.4.4.2.3 Argentina mHealth Market by Applications
9.4.4.3 UAE mHealth Market
9.4.4.3.1 UAE mHealth Market by Type
9.4.4.3.2 UAE mHealth Market by Stakeholders
9.4.4.3.3 UAE mHealth Market by Applications
9.4.4.4 Saudi Arabia mHealth Market
9.4.4.4.1 Saudi Arabia mHealth Market by Type
9.4.4.4.2 Saudi Arabia mHealth Market by Stakeholders
9.4.4.4.3 Saudi Arabia mHealth Market by Applications
9.4.4.5 South Africa mHealth Market
9.4.4.5.1 South Africa mHealth Market by Type
9.4.4.5.2 South Africa mHealth Market by Stakeholders
9.4.4.5.3 South Africa mHealth Market by Applications
9.4.4.6 Nigeria mHealth Market
9.4.4.6.1 Nigeria mHealth Market by Type
9.4.4.6.2 Nigeria mHealth Market by Stakeholders
9.4.4.6.3 Nigeria mHealth Market by Applications
9.4.4.7 Rest of LAMEA mHealth Market
9.4.4.7.1 Rest of LAMEA mHealth Market by Type
9.4.4.7.2 Rest of LAMEA mHealth Market by Stakeholders
9.4.4.7.3 Rest of LAMEA mHealth Market by Applications
Chapter 10. Company Profiles
10.1 Bayer AG
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 Medtronic PLC
10.2.1 Company overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Acquisition and Mergers:
10.2.6 SWOT Analysis
10.3 Johnson and Johnson
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental &Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Koninklijke Philips N.V.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisition and Mergers:
10.4.5.2 Product Launches and Product Expansions:
10.4.6 SWOT Analysis
10.5 DexCom, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.6 Samsung Electronics Co., Ltd. (Samsung Group)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.6.6 SWOT Analysis
10.7 Omron Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Partnerships, Collaborations, and Agreements:
10.7.5.2 Product Launches and Product Expansions:
10.7.6 SWOT Analysis
10.8 AllScripts Healthcare Solutions, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Acquisition and Mergers:
10.9 Sanofi S.A.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Partnerships, Collaborations, and Agreements:
10.1 Cerner Corporation
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Partnerships, Collaborations, and Agreements:



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[モバイルヘルスの世界市場:種類別(サービス、デバイス)、サービス別(監視サービス、診断サービス、ヘルスケアシステム強化サービス、その他)、デバイス別(BPモニター、心臓モニター、脈拍酸素濃度計、血糖計、無呼吸・睡眠モニター、神経モニター、ウェアラブルフィットネスセンサーデバイス・心拍数メーター、その他)、ステークホルダー別(モバイルオペレーター、デバイスベンダー、ヘルスケアプロバイダー、コンテンツプレーヤー)、用途別(心臓血管疾患、糖尿病、呼吸器、神経、その他)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆